Recent Reports


2011-11-14: Biotechnology and Pharmaceuticals Report
5 leading Analysts; and top management from 4 Sector Firms examine this industry.
Order this Report
More Information

2011-10-31: Health Care IT Report
4 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-10-17: Medical Research, Diagnostic Substances & Life Science Tools Report
4 leading Analysts; and top management from 3 Sector Firms examine this industry.
Order this Report
More Information

2011-10-03: Medical Real Estate Report
3 leading Analysts; and top management from 3 Sector Firms examine industry.
Order this Report
More Information

2011-07-11: Medical Devices Report
5 leading Analysts; and top management from 12 Sector Firms examine this industry.
Order this Report
More Information

2011-06-27: Health Care IT Report
6 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

2011-06-13: Medical Research, Diagnostic Substances & Life Science Tools Report
5 leading Analysts; and top management from 3 Sector Firm examine this industry.
Order this Report
More Information

2011-04-04: Biotechnology and Pharmaceuticals Report
3 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-01-24: Medical Devices Report
3 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Company Interview Excerpt
MARTIN NASH - GENETRONICS BIOMEDICAL LIMITED (GEB)


Full article published: 12/04/2000


For Subscribers

Get this article online now!

Order just this article
TWST: Could you give us a history and overview of Genetronics?
Mr. Nash: Genetronics was founded in 1983 to exploit a technology that had been developed at the Max Plank Institute in Munich in the early 1970s. The technique involves fluidizing cell walls in such a way that molecules can have access to the interior of these cells to, for example, prompt the cells to fuse for the manufacturing of monoclonal antibodies. This technology was sort of a laboratory technique and the company was originally conceived to design, develop, standardize manufacture and distribute hardware that would make it possible for all labs to do this technique. The first product was launched in 1985 and now in molecular biology labs it is a ubiquitous technique throughout the world. Around 1992 the company began to receive more and more requests from customers to find ways to take this technology from the test tube lab bench and start to use it on rodents to help researchers to go from the test tube to mice and rats. Around 1993, we found a way to do that. I joined in February 1994 to write a business plan to expand the business because it appeared to us that if we can take the technology to rodents we could take it to large animals like me. There are a number of medical conditions where it is important that the active agent, the molecule of interest, not simply sit on top of the cell but actually gain access to the DNA and the nucleus itself. Our mission in life is to facilitate the intracellular delivery of molecules of one sort or another for the treatment of acquired or genetic disease.

TWST: What is the technique in layman's terms?
Mr. Nash: One of the reasons I joined the company is because the technique is elegantly simple. The outer membrane of all cells, whether they be insect cells or mammalian cells or tumor cells, consists of quite complex layers of lipids. Molecules find it difficult to work their way through these layers to get to the inside of the cell. Under properly configured conditions of electric field it is possible to reorganize that outer membrane temporarily, probably for under a minute, but during that minute what happens is a transient permeability, a temporary reorganization of this complex series of lipid layers. The reorganization or the permeablization is manifested by the appearance of probably thousands per cell of aqueous channels, or water columns. So now instead of the molecule having to work its way through a dense and complex mosaic of lipids it simply goes straight down what might be thought of as a chimney of water. This facilitates the entry of the molecule to the interior of the cell. As soon as the electric field stops the cell begins to reform itself and in a minute or so the cell wall is just like it was in the beginning but now the molecule is on the inside of the cell not the outside.

 

Tickers included in this excerpt: GEB

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.